Proteomic analysis of the murine liver in response to a combined exposure to psychological stress and 7,12-dimethylbenz(a)anthracene

Journal of Proteome Research

Volumn 9, Issue 1, 2010, Pages 509-520

  Flint, Melanie S ^a   Hood, Brian L ^a   Sun, Mai ^a   Stewart, Nicolas A ^b   Jones Laughner, Jacqueline ^a   Conrads, Thomas P ^a,c  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Cytochrome P450; DMBA; Liver; Proteomics; Stress

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CYTOCHROME P450 1A2; CYTOCHROME P450 2J5; CYTOCHROME P450 3A11; CYTOCHROME P450 ISOENZYME; DNA TOPOISOMERASE (ATP HYDROLYSING); GLUCURONOSYLTRANSFERASE; LIVER PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; LIVER CARCINOGENESIS; LIVER METABOLISM; MENTAL STRESS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TANDEM MASS SPECTROMETRY;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CLUSTER ANALYSIS; CYTOCHROME P-450 ENZYME SYSTEM; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; PEPTIDES; PROTEOME; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; STRESS, PSYCHOLOGICAL; TANDEM MASS SPECTROMETRY;

MURINAE; MUS;

EID: 73649111402     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900861j     Document Type: Article

References (47)

1. Shimada, T. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab. Pharmacokinet. 2006, 21 (4), 257-76.
2. Shimada, T.; Fujii-Kuriyama, Y. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci. 2004, 95 (1), 1-6.
3. Shimada, T.; Sugie, A.; Yamada, T.; Kawazoe, H.; Hashimoto, M.; Azuma, E.; Nakajima, T.; Inoue, K.; Oda, Y. Dose-response studies on the induction of liver cytochromes P4501A1 and 1B1 by polycyclic aromatic hydrocarbons in arylhydrocarbon-responsive C57BL/6J mice. Xenobiotica 2003, 33 (9), 957-71.
4. Pignatelli, D.; Magalhaes, M. M.; Magalhaes, M. C. Direct effects of stress on adrenocortical function. Horm. Metab. Res. 1998, 30 (6-7), 464-74.
5. Papadimitriou, A, P. K. Regulation of the hypothalamic-pituitary-adrenal axis. Neuroimmunomodulation 2009, 16 (5), 265-71.
6. Longui, CA, F. C.; H, R. -E. J. 19506386., P. P., Evaluation of glucocorticoid sensitivity and its potential clinical applicability. Horm. Res. 2009, 71 (6), 305-9.
7. Weitl, N, S. R. Distinct interactions of human beta1- and beta2-adrenoceptors with isoproterenol, epinephrine, norepinephrine, and dopamine. J. Pharmacol. Exp. Ther. 2008, 327 (3), 760-9.
8. Lutgendorf, S. K.; Cole, S.; Costanzo, E.; Bradley, S.; Coffin, J.; Jabbari, S.; Rainwater, K.; Ritchie, J. M.; Yang, M.; Sood, A. K. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin. Cancer Res. 2003, 9 (12), 4514-21.
9. Pulaski, L.; Kania, K.; Ratajewski, M.; Uchiumi, T.; Kuwano, M.; Bartosz, G. Differential regulation of the human MRP2 and MRP3 gene expression by glucocorticoids. J. Steroid Biochem. Mol. Biol. 2005, 96 (3-4), 229-34.
10. Konstandi, M.; Kostakis, D.; Johnson, E.; Lang, M. A.; Marselos, M. Evidence of alpha2-adrenoceptor involvement in B[alpha]P induction processes of drug-metabolizing enzymes: the effect of stress. Eur. J. Drug Metab. Pharmacokinet. 1998, 23 (4), 491-5.
11. Zafir, A.; Banu, N. Modulation of in vivo oxidative status by exogenous corticosterone and restraint stress in rats. Stress 2009, 12 (2), 167-77.
12. Konstandi, M.; Marselos, M.; Radon-Camus, A. M.; Johnson, E.; Lang, M. A. The role of stress in the regulation of drug metabolizing enzymes in mice. Eur. J. Drug Metab. Pharmacokinet. 1998, 23 (4), 483-90.
13. Pollack, G. M.; Browne, J. L.; Marton, J.; Haberer, L. J. Chronic stress impairs oxidative metabolism and hepatic excretion of model xenobiotic substrates in the rat. Drug Metab. Dispos. 1991, 19 (1), 130-4.
14. Konstandi, M.; Johnson, E.; Lang, M. A.; Camus-Radon, A. M.; Marselos, M. Stress modulates the enzymatic inducibility by benzo[alpha]pyrene in the rat liver. Pharmacol. Res. 2000, 42 (3), 205-11.
15. Mikhailova, O. N.; Gulyaeva, L. F.; Filipenko, M. L. Gene expression of drug metabolizing enzymes in adult and aged mouse liver: a modulation by immobilization stress. Toxicology 2005, 210 (2-3), 189-96.
16. Redlich, G.; Zanger, U. M.; Riedmaier, S.; Bache, N.; Giessing, A. B.; Eisenacher, M.; Stephan, C.; Meyer, H. E.; Jensen, O. N.; Marcus, K. Distinction between human cytochrome P450 (CYP) isoforms and identification of new phosphorylation sites by mass spectrometry. J. Proteome Res. 2008, 7 (11), 4678-88.
17. Seibert, C. D. B.; Fuller, B. J.; Patterson, L. H.; Griffiths, W. J.; Wang, Y. Multiple-Approaches to the Identification and Quantification of Cytochromes P450 in Human Liver Tissue by Mass Spectrometry. J. Proteome Res. 2009, 8 (4), 1672-1681.
18. Wilson-Grady, J. T.; Villen, J.; Gygi, S. P. Phosphoproteome analysis of fission yeast. J. Proteome Res. 2008, 7 (3), 1088-97.
19. Zhai, B.; Villen, J.; Beausoleil, S. A.; Mintseris, J.; Gygi, S. P. Phosphoproteome analysis of Drosophila melanogaster embryos. J. Proteome Res. 2008, 7 (4), 1675-82.
20. Flint, M. S.; Carroll, J. E.; Jenkins, F. J.; Chambers, W. H.; Han, M. L.; Baum, A. Genomic profiling of restraint stress-induced alterations in mouse T lymphocytes. J. Neuroimmunol. 2005, 167 (1-2), 34-44.
21. Flint, M. S.; Tinkle, S. S. C57BL/6 mice are resistant to acute restraint modulation of cutaneous hypersensitivity. Toxicol. Sci. 2001, 62 (2), 250-6.
22. Flint, M. S.; Valosen, J. M.; Johnson, E. A.; Miller, D. B.; Tinkle, S. S. Restraint stress applied prior to chemical sensitization modulates the development of allergic contact dermatitis differently than restraint prior to challenge. J. Neuroimmunol. 2001, 113 (1), 72-80.
23. Shevchenko, A.; Tomas, H.; Havlis, J.; Olsen, J. V.; Mann, M. Ingel digestion for mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 2006, 1 (6), 2856-60.
24. Nelson, D. R.; Zeldin, D. C.; Hoffman, S. M.; Maltais, L. J.; Wain, H. M.; Nebert, D. W. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 2004, 14 (1), 1-18.
25. Moran, J. H.; Mitchell, L. A.; Bradbury, J. A.; Qu, W.; Zeldin, D. C.; Schnellmann, R. G.; Grant, D. F. Analysis of the cytotoxic properties of linoleic acid metabolites produced by renal and hepatic P450s.[erratum appears in Toxicol Appl Pharmacol 2001 Mar 15;171(3):196]. Toxicol. Appl. Pharmacol. 2000, 168 (3), 268-79.
26. Xie, Q.; Zhang, Q. Y.; Zhang, Y.; Su, T.; Gu, J.; Kaminsky, L. S.; Ding, X. Induction of mouse CYP2J by pyrazole in the eye, kidney, liver, lung, olfactory mucosa, and small intestine, but not in the heart. Drug Metab. Dispos. 2000, 28 (11), 1311-6.
27. Satoh, T.; Hosokawa, M. Structure, function and regulation of carboxylesterases. Chem.-Biol. Interact. 2006, 162 (3), 195-211.
28. Takakusa, H.; Masumoto, H.; Mitsuru, A.; Okazaki, O.; Sudo, K. Markers of electrophilic stress caused by chemically reactive metabolites in human hepatocytes. Drug Metab. Dispos. 2008, 36 (5), 816-23.
29. Liu, Y.; Xiao, W. Bidirectional regulation of two DNA-damage-inducible genes, MAG1 and DDI1, from Saccharomyces cerevisiae. Mol. Microbiol. 1997, 23 (4), 777-89.
30. Stark, K.; Guengerich, F. P. Characterization of orphan human cytochromes P450. Drug Metab. Rev. 2007, 39 (2-3), 627-37.
31. Allegri, G.; Ragazzi, E.; Bertazzo, A.; Costa, C. V. Enzyme activities along the kynurenine pathway in mice. Adv. Exp. Med. Biol. 2003, 527, 497-510.
32. Hines, R. N.; Cashman, J. R.; Philpot, R. M.; Williams, D. E.; Ziegler, D. M. The mammalian flavin-containing monooxygenases: molecular characterization and regulation of expression. Toxicol. Appl. Pharmacol. 1994, 125 (1), 1-6.
33. Grad, L. I.; Lemire, B. D. Mitochondrial complex I mutations in Caenorhabditis elegans produce cytochrome c oxidase deficiency, oxidative stress and vitamin-responsive lactic acidosis. Hum. Mol. Genet. 2004, 13 (3), 303-14.
34. Lankat-Buttgereit, B.; Goke, R. The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol. Cell 2009, 101 (6), 309-17.
35. Shou, M.; Korzekwa, K. R.; Krausz, K. W.; Buters, J. T.; Grogan, J.; Goldfarb, I.; Hardwick, J. P.; Gonzalez, F. J.; Gelboin, H. V. Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthracene. Mol. Carcinogenesis 1996, 17 (4), 241-9.
36. Morrison, V. M.; Burnett, A. K.; Forrester, L. M.; Wolf, C. R.; Craft, J. A. The contribution of specific cytochromes P-450 in the metabolism of 7,12-dimethylbenz[a]anthracene in rat and human liver microsomal membranes. Chem.-Biol. Interact. 1991, 79 (2), 179-96.
37. Morrison, V. M.; Burnett, A. K.; Craft, J. A. Metabolism of 7,12-dimethylbenz[a]anthracene in hepatic microsomal membranes from rats treated with isoenzyme-selective inducers of cytochromes P450. Biochem. Pharmacol. 1991, 41 (10), 1505-12.
38. Lambard, S. E.; Burnett, A. K.; Wolf, C. R.; Craft, J. A. The role of specific cytochromes P450 in the formation of 7,12-dimethylbenz(a)anthracene- protein adducts in rat liver microsomes in vitro. Biochem. Pharmacol. 1991, 42 (8), 1529-35.
39. Bhadhprasit, W.; Sakuma, T.; Hatakeyama, N.; Fuwa, M.; Kitajima, K.; Nemoto, N. Involvement of glucocorticoid receptor and pregnane X receptor in the regulation of mouse CYP3A44 female-predominant expression by glucocorticoid hormone. Drug Metab. Dispos. 2007, 35 (10), 1880-5.
40. El-Sankary, W.; Bombail, V.; Gibson, G. G.; Plant, N. Glucocorticoid-mediated induction of CYP3A4 is decreased by disruption of a protein: DNA interaction distinct from the pregnane X receptor response element. Drug Metab. Dispos. 2002, 30 (9), 1029-34.
41. Haag, M.; Fautrel, A.; Guillouzo, A.; Frossard, N.; Pons, F. Expression of cytochromes P450 3A in mouse lung: effects of dexamethasone and pregnenolone 16alpha-carbonitrile. Arch. Toxicol. 2003, 77 (3), 145-9.
42. Down, M. J.; Arkle, S.; Mills, J. J. Regulation and induction of CYP3A11, CYP3A13 and CYP3A25 in C57BL/6J mouse liver. Arch. Biochem. Biophys. 2007, 457 (1), 105-10.
43. O'Malley, F. P.; Chia, S.; Tu, D.; Shepherd, L. E.; Levine, M. N.; Bramwell, V. H.; Andrulis, I. L.; Pritchard, K. I. Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy.[see comment]. J. Natl. Cancer Inst. 2009, 101 (9), 644-50.
44. Simon, R.; Atefy, R.; Wagner, U.; Forster, T.; Fijan, A.; Bruderer, J.; Wilber, K.; Mihatsch, M. J.; Gasser, T.; Sauter, G. HER-2 und TOP 2A Genamplifikationen beim Harnblasenkarzinom. Verh. Dtsch. Ges. Pathol. 2002, 86, 176-83.
45. Rosa, H.; Parise, E. R. Is there a place for serum laminin determination in patients with liver disease and cancer. World J. Gastroenterol. 2008, 14 (23), 3628-32.
46. Rescan, P. Y.; Clement, B.; Yamada, Y.; Segui-Real, B.; Baffet, G.; Guguen-Guillouzo, C.; Guillouzo, A. Differential expression of laminin chains and receptor (LBP-32) in fetal and neoplastic hepatocytes compared to normal adult hepatocytes in vivo and in culture. Am. J. Pathol. 1990, 137 (3), 701-9.
47. Tam, C. W.; Liu, V. W.; Leung, W. Y.; Yao, K. M.; Shiu, S. Y. The autocrine human secreted PDZ domain-containing protein 2 (sPDZD2) induces senescence or quiescence of prostate, breast and liver cancer cells via transcriptional activation of p53. Cancer Lett. 2008, 271 (1), 64-80.